SCHEMBL23833719

SCHEMBL23833719

CCOC(=O)c1nc(Br)c(-c2ccccc2)o1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
KMT2A Q03164 5/20 0.51
HPGD P15428 5/20 0.51
KDM4E B2RXH2 5/20 0.51
HSD17B10 Q99714 3/20 0.51
TARBP2 Q15633 2/20 0.50
MEN1 O00255 3/20 0.49
PRNP P04156 1/20 0.49
GAA P10253 2/20 0.49
LMNA P02545 2/20 0.49
MAPT P10636 2/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
NPC1 O15118 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ADORA3 P0DMS8 2/20 0.46
CDC7 O00311 1/20 0.45
TRPM8 Q7Z2W7 1/20 0.45
DBF4 Q9UBU7 1/20 0.45
PLA2G1B P04054 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2117681 0.84 NR4A2 (0.63) ALDH1A1KMT2AHPGDKDM4EHSD17B10
SCHEMBL8558011 0.78 TP53 (0.55) ALDH1A1KMT2AHPGDKDM4EHSD17B10
SCHEMBL22557344 0.76 ALOX5 (0.55) ALDH1A1KMT2AHPGDKDM4EHSD17B10
SCHEMBL7500361 0.75 PTGS2 (0.62) ALDH1A1KMT2AHPGDKDM4EHSD17B10
SCHEMBL7501340 0.75 PTGS2 (0.62) ALDH1A1KMT2AHPGDKDM4EHSD17B10
SCHEMBL9025944 0.75 MAPT (0.52) ALDH1A1KMT2AHPGDKDM4EHSD17B10
SCHEMBL7505599 0.74 CA1 (0.58) ALDH1A1KMT2AHPGDKDM4EHSD17B10
SCHEMBL7499057 0.74 CA1 (0.58) ALDH1A1KMT2AHPGDKDM4EHSD17B10
SCHEMBL1968359 0.74 TARBP2 (0.59) ALDH1A1KMT2AHPGDKDM4EHSD17B10
SCHEMBL28462846 0.74 ALDH1A1 (0.52) ALDH1A1KMT2AHPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
EP-4121029-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF Amathus Therapeutics, Inc. (US) 2023-01-25 EP disclosed
WO-2021188880-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 ALDH1A1 2569/4885KMT2A 4864/4885HPGD 2112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.